Estrogen receptor α is a novel target of the Von Hippel-Lindau protein and is responsible for the proliferation of VHL-deficient cells under hypoxic conditions

References

• Kaelin WG Jr.. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2002; 2:673 - 82; http://dx.doi.org/10.1038/nrc885; PMID: 12209156
   PubMed Web of Science ®Google Scholar
• Kaelin WG Jr.. Von Hippel-Lindau disease. Annu Rev Pathol 2007; 2:145 - 73; http://dx.doi.org/10.1146/annurev.pathol.2.010506.092049; PMID: 18039096
   PubMed Web of Science ®Google Scholar
• Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004; 5:343 - 54; http://dx.doi.org/10.1038/nrm1366; PMID: 15122348
   PubMed Web of Science ®Google Scholar
• Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J Clin Oncol 2004; 22:4991 - 5004; http://dx.doi.org/10.1200/JCO.2004.05.061; PMID: 15611513
   PubMed Web of Science ®Google Scholar
• Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992; 12:5447 - 54; PMID: 1448077
   PubMed Web of Science ®Google Scholar
• Yoon D, Pastore YD, Divoky V, Liu E, Mlodnicka AE, Rainey K, et al. Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J Biol Chem 2006; 281:25703 - 11; http://dx.doi.org/10.1074/jbc.M602329200; PMID: 16787915
   PubMed Web of Science ®Google Scholar
• Karin M, Cao Y, Greten FR, Li ZW. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2002; 2:301 - 10; http://dx.doi.org/10.1038/nrc780; PMID: 12001991
   PubMed Web of Science ®Google Scholar
• Boutin AT, Weidemann A, Fu Z, Mesropian L, Gradin K, Jamora C, et al. Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell 2008; 133:223 - 34; http://dx.doi.org/10.1016/j.cell.2008.02.038; PMID: 18423195
   PubMed Web of Science ®Google Scholar
• Concolino G, Marocchi A, Conti C, Tenaglia R, Di Silverio F, Bracci U. Human renal cell carcinoma as a hormone-dependent tumor. Cancer Res 1978; 38:4340 - 4; PMID: 698974
   PubMed Web of Science ®Google Scholar
• Wolf DC, Goldsworthy TL, Donner EM, Harden R, Fitzpatrick B, Everitt JI. Estrogen treatment enhances hereditary renal tumor development in Eker rats. Carcinogenesis 1998; 19:2043 - 7; http://dx.doi.org/10.1093/carcin/19.11.2043; PMID: 9855022
   PubMed Web of Science ®Google Scholar
• Stefaniak T, Krajewski J, Kobiela J, Makarewicz W, Stanek A, Asano M, et al. Protein oxidation in male Syrian hamster kidney during estrogen-induced carcinogenesis. Pathophysiology 2002; 8:269 - 73; http://dx.doi.org/10.1016/S0928-4680(02)00019-6; PMID: 12100973
   PubMedGoogle Scholar
• Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R. Estrogen receptor alpha polymorphisms and renal cell carcinoma--a possible risk. Mol Cell Endocrinol 2003; 202:109 - 16; http://dx.doi.org/10.1016/S0303-7207(03)00071-6; PMID: 12770739
   PubMed Web of Science ®Google Scholar
• Seagroves TN, Peacock DL, Liao D, Schwab LP, Krueger R, Handorf CR, et al. VHL deletion impairs mammary alveologenesis but is not sufficient for mammary tumorigenesis. Am J Pathol 2010; 176:2269 - 82; http://dx.doi.org/10.2353/ajpath.2010.090310; PMID: 20382704
   PubMed Web of Science ®Google Scholar
• Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P. Functional domains of the human estrogen receptor. Cell 1987; 51:941 - 51; http://dx.doi.org/10.1016/0092-8674(87)90581-2; PMID: 3690665
   PubMed Web of Science ®Google Scholar
• Bukovsky A, Ayala ME, Dominguez R, Keenan JA, Wimalasena J, Elder RF, et al. Changes of ovarian interstitial cell hormone receptors and behavior of resident mesenchymal cells in developing and adult rats with steroid-induced sterility. Steroids 2002; 67:277 - 89; http://dx.doi.org/10.1016/S0039-128X(01)00159-3; PMID: 11856552
   PubMed Web of Science ®Google Scholar
• Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, et al. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 1994; 55:1092 - 102; PMID: 7977367
   PubMed Web of Science ®Google Scholar
• Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG Jr.. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 1995; 269:1444 - 6; http://dx.doi.org/10.1126/science.7660130; PMID: 7660130
   PubMed Web of Science ®Google Scholar
• Wilcken NR, Prall OW, Musgrove EA, Sutherland RL. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens. Clin Cancer Res 1997; 3:849 - 54; PMID: 9815758
   PubMed Web of Science ®Google Scholar
• Park SH, Cheung LW, Wong AS, Leung PC. Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Mol Endocrinol 2008; 22:2085 - 98; http://dx.doi.org/10.1210/me.2007-0512; PMID: 18550773
   PubMed Web of Science ®Google Scholar
• Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Shetuni B, et al. ERalpha signaling through slug regulates E-cadherin and EMT. Oncogene 2010; 29:1451 - 62; http://dx.doi.org/10.1038/onc.2009.433; PMID: 20101232
   PubMed Web of Science ®Google Scholar
• Lee SH, Lee SJ, Jung YS, Xu Y, Kang HS, Ha NC, et al. Blocking of p53-Snail binding, promoted by oncogenic K-Ras, recovers p53 expression and function. Neoplasia 2009; 11:22 - 31, 6p, 31; PMID: 19107228
   PubMed Web of Science ®Google Scholar
• Dubik D, Dembinski TC, Shiu RP. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res 1987; 47:6517 - 21; PMID: 3677090
   PubMed Web of Science ®Google Scholar
• Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399:271 - 5; http://dx.doi.org/10.1038/20459; PMID: 10353251
   PubMed Web of Science ®Google Scholar
• Stafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM, Sadler GR. Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J Urol 2008; 179:1704 - 8; http://dx.doi.org/10.1016/j.juro.2008.01.027; PMID: 18343443
   PubMed Web of Science ®Google Scholar
• Mack FA, Rathmell WK, Arsham AM, Gnarra J, Keith B, Simon MC. Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth. Cancer Cell 2003; 3:75 - 88; http://dx.doi.org/10.1016/S1535-6108(02)00240-4; PMID: 12559177
   PubMed Web of Science ®Google Scholar
• Stolle C, Glenn G, Zbar B, Humphrey JS, Choyke P, Walther M, et al. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene. Hum Mutat 1998; 12:417 - 23; http://dx.doi.org/10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K; PMID: 9829911
   PubMed Web of Science ®Google Scholar